Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $157.6300 (-1.48%) ($157.6300 - $160.9700) on Thu. Nov. 4, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.92% (three month average) | RSI | 86 | Latest Price | $157.6300(-1.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.5% a day on average for past five trading days. | Weekly Trend | LGND advances 9% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(59%) IWM(57%) IWC(54%) IWN(53%) | Factors Impacting LGND price | LGND will decline at least -1.46% in a week (0% probabilities). VIXM(-28%) VXX(-17%) UUP(-17%) UNG(-5%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.46% (StdDev 2.92%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $154.74(1.87%) | 10 Day Moving Average | $147.82(6.64%) | 20 Day Moving Average | $139.11(13.31%) | To recent high | -1.5% | To recent low | 53.9% | Market Cap | $2.533b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |